Skip to content

Sun Pharma ARC partner gets USFDA setback on drug approval application

Sun Pharma Advanced Research Company says Ocuvex Therapeutics received a USFDA Complete Response Letter for PDP-716, shares fall on regulatory setback​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *